Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Positive thinking

With no money in the bank and the prospect of more coming in contingent on the ongoing legal saga I don't know what a new CEO could do for us. If and when significant money comes through and shareholders have been given a chance to exit because of PPS appreciation and dividends then the company will have to consider MA activities to sustain the company in the future. We have sunset patents so if the company wants to continue they will need an alternate source of income. At this point a new and dynamic CEO will be needed and the new shareholder base can decide if it is worth it to hang around. I personally will not be here so I am just waiting for the first part of the equation to happen. And waiting and waiting .............

GL

Share
New Message
Please login to post a reply